Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1 Academic Article uri icon

Overview

MeSH Major

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • HIV Infections
  • HIV-1
  • Hepacivirus
  • Hepatitis C, Chronic
  • Uridine Monophosphate

abstract

  • Ledipasvir and sofosbuvir for 12 weeks provided high rates of sustained virologic response in patients coinfected with HIV-1 and HCV genotype 1 or 4. (Funded by Gilead Sciences; ION-4 ClinicalTrials.gov number, NCT02073656.).

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4892372

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1501315

PubMed ID

  • 26196665

Additional Document Info

start page

  • 705

end page

  • 13

volume

  • 373

number

  • 8